Le Registre des lobbyistes
Objets | Détails | Catégories |
---|---|---|
Santé
|
Bill C-64: An Act respecting pharmacare, with a particular focus on access to medicines and rare disease and orphan drug policies.
|
Politique ou Programme,
Proposition législative, Projet de loi ou résolution
|
Santé
|
Engagement with officials on issues related to the National Strategy for Rare Disease Drugs, and other policies or programs related to rare diseases.
|
Politique ou Programme
|
Budget,
Santé
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including addressing any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with Canada's Drug Agency and/or other pan-Canadian health organizations.
|
Politique ou Programme
|
Santé
|
Federally-funded public drug plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Politique ou Programme
|
Industrie,
Propriété intellectuelle,
Santé
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board.
|
Politique ou Programme
|
Industrie,
Santé
|
Innovation, Science and Economic Development Canada regarding the Innovation and Skills Agenda and other government policies and programs related to incentivizing research and development activities in Canada, including the Biomanufacturing and Life Sciences Strategy.
|
Politique ou Programme
|
Santé
|
Regulatory amendments and/or guidelines and/or policies related to the Food and Drugs Act and Health Canada review of drugs for rare diseases.
|
Politique ou Programme,
Règlement
|
Objets | Détails | Catégories |
---|---|---|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including addressing any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with the Canadian Agency for Drugs and Technologies in Health (CADTH) and/or other pan-Canadian health organizations.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Federally-funded public drug plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Innovation, Science and Economic Development Canada regarding the Innovation and Skills Agenda and other government policies and programs related to incentivizing research and development activities in Canada, including the Biomanufacturing and Life Sciences Strategy.
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Policies related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
|
Politique ou Programme
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Regulatory amendments and/or guidelines and/or policies related to the Food and Drugs Act and Health Canada review of drugs for rare diseases.
|
Politique ou Programme,
Règlement
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
The federal role in considering developing and/or funding a national pharmacare program, including engagement with the Advisory Council on the Implementation of National Pharmacare and its Secretariat on issues related to access to medicines and rare disease and orphan drug policies, including the evolving Drugs for Rare Diseases Strategy.
|
Politique ou Programme
|
Techniques de communication déjà utilisées ou qui seront utilisées au cours de l'engagement :